Lawsuit Information Center

April 14, 2026

Uber Sexual Assault Lawsuits

Uber is facing one of the largest waves of passenger sexual assault lawsuits in U.S. history. Survivors across the country allege that Uber drivers sexually assaulted them and that the company is legally responsible because it failed to screen drivers properly, ignored prior complaints, and did not implement basic safety measures.

These claims are now consolidated in In re: Uber Technologies Inc., Passenger Sexual Assault Litigation (MDL No. 3084) in the Northern District of California. As of April 2026, 3,391 plaintiffs in 30 states have joined the MDL, with this number expected to continue rising throughout 2026.

The first MDL trial began in January 2026, and the jury returned an $8.5 million verdict in early February. Our lawyers believe these are exceptionally strong cases. The evidence points to a pattern: repeated warnings about dangerous drivers, no action from Uber, and preventable assaults that followed. In the courtroom, that is the kind of timeline juries understand and respond to. It is also the kind of fact pattern that can lead to substantial Uber sexual assault settlement amounts.

April 14, 2026

Depo Provera Lawsuit Settlements

by Ronald V. Miller, Jr.

This page is for victims considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates on these claims, explain the litigation process, and predict Depo Provera settlement amounts.

A new scientific study has provided stunning evidence that using Depo-Provera can cause brain tumors. Women who used Depo-Provera and subsequently developed a meningioma brain tumor can file a Depo-Provera lawsuit seeking financial compensation. This new evidence is leading to a wave of Depo-Provera lawsuits nationwide.

Our lawyers are speaking to over 100 women a week who used Depo-Provera and have been diagnosed with meningioma. Our law firm is committed to this litigation and handling Depo-Provera lawsuits for women who had at least two injections and were later diagnosed with a meningioma brain tumor. If you meet these criteria, we will make the process of signing up for this litigation easy for you. Contact our Depo-Provera lawyers today at 800-553-8082 or contact us online.

April 14, 2026

Camp Lejeune Lawsuit News and Updates

by Ronald V. Miller, Jr.

This page provides updates on Camp Lejeune lawsuits. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

Latest Camp Lejeune Lawsuit Updates for 2026

April 14, 2026

Wire Grill Brush Lawsuit

by Ronald V. Miller, Jr.

If you swallowed a wire bristle from a grill brush or found a metal fragment in your food after cleaning your grill, you are not imagining things or overreacting. A wire bristle from a grill cleaning brush can break off during normal use, stick to a burger or hot dog without anyone seeing it, and end up in your throat, stomach, or intestines. The injuries range from sharp throat pain and trouble swallowing to bowel perforation requiring emergency surgery.

In early 2026, the U.S. Consumer Product Safety Commission recalled more than 13 million wire grill brushes from Weber and Nexgrill after confirming that detached bristles were sticking to food and causing serious internal injuries. If you or someone in your family was hurt, there may be a product liability claim against the manufacturer.

The CDC warned about this hazard years ago, and in early 2026, the U.S. Consumer Product Safety Commission announced two massive recalls involving Weber and Nexgrill wire bristle brushes because detached bristles can stick to food and cause serious internal injuries that may require surgery.

April 13, 2026

Ocaliva Lawsuit 2026

by Ronald V. Miller, Jr.

Ocaliva was supposed to protect your liver. Instead, for many, it destroyed it.

Ocaliva was sold as a treatment for primary biliary cholangitis, a chronic disease that damages the bile ducts in the liver. It came to market with promise. It left the market under a cloud of serious liver injury, transplant, and death.

By late 2025, the FDA had withdrawn approval of Ocaliva after concluding the postmarketing evidence showed excess liver transplants and deaths, and did not verify the clinical benefit the company needed to prove. Intercept then pulled the drug from the United States market.

April 10, 2026

NEC Baby Formula Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.

Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make a lot of allegations. But at their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families and give them a choice.

If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to participate in a class action lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.

April 7, 2026

Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are actively reviewing hair relaxer cancer lawsuits across all 50 states. This page provides:

Detailed news and updates on the chemical hair relaxer litigation,
Insights from our hair relaxer attorneys on how these lawsuits may unfold,

April 7, 2026

Mormon Church Sex Abuse Lawsuits

by Ronald V. Miller, Jr.

On this page, our lawyers will discuss LDS sexual abuse lawsuits against the Mormon Church (Church of Jesus Christ of Latter-day Saints).

We will explain the legal requirements for bringing a Mormon Church sex abuse lawsuit, and our attorneys will also examine the expected average settlement payout value of remaining cases.

We expect a global LDS Church sex abuse settlement in 2025. If this happens, you want to act now to participate in a global settlement. Contact us today at 800-553-8082 or get a free consultation.

April 7, 2026

Pitocin Overdose Birth Injury Lawsuit

by Ronald V. Miller, Jr.

This page is about birth injury lawsuits that involve the overdose or misuse of Pitocin during the birth process. Our lawyers talk about the mistakes doctors and nurses make that lead to HIE, cerebral palsy, and other birth injuries, and we look at settlement amounts and jury payouts in these cases in 2026.

If you have a potential lawsuit, reach out to us, and we can talk to you about your options for compensation. Call today at 800-553-8082 and speak with a birth injury medical malpractice attorney or get an online case evaluation.

What is Pitocin Used For?

April 6, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.